LifeMD Inc reports results for the quarter ended September 30 - Earnings Summary

LifeMD

08/11/2024 21:46

* LifeMD Inc  LFMD.OQ  reported a quarterly adjusted loss
of 14
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -20 cents.  The mean expectation of six analysts for the
quarter was for a loss of 12 cents per share. Wall Street
expected results to range from -15 cents to -6 cents per share.
    * Revenue rose 38.3% to $53.39 million from a year ago;
analysts
expected $53.80 million. 
    * LifeMD Inc's reported EPS for the quarter was a loss of 14
cents​.
    * The company reported a quarterly loss of $5.91 million.
    * LifeMD Inc shares had fallen by 2.1% this quarter and
lost 38.1%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for LifeMD Inc is
12.00 
This summary was machine generated from LSEG data November 8 at
09:46 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.12          -0.14          Missed
 Jun. 30 2024                     -0.19          
 Mar. 31 2024                     -0.19          
 Dec. 31 2023      -0.14          -0.12          Beat